504 related articles for article (PubMed ID: 32766145)
1. Reduced Expression of
Shi Y; Zheng C; Jin Y; Bao B; Wang D; Hou K; Feng J; Tang S; Qu X; Liu Y; Che X; Teng Y
Front Oncol; 2020; 10():1126. PubMed ID: 32766145
[TBL] [Abstract][Full Text] [Related]
2. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
3. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
[TBL] [Abstract][Full Text] [Related]
5. METTL3 Is Suppressed by Circular RNA circMETTL3/miR-34c-3p Signaling and Limits the Tumor Growth and Metastasis in Triple Negative Breast Cancer.
Ruan HG; Gu WC; Xia W; Gong Y; Zhou XL; Chen WY; Xiong J
Front Oncol; 2021; 11():778132. PubMed ID: 35004298
[TBL] [Abstract][Full Text] [Related]
6. m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1.
Zhou W; Xian Q; Wang Q; Wu C; Yan H; Li X; Lu L; Wu C; Zhu D; Xu X; Wu J
J Oncol; 2021; 2021():8875424. PubMed ID: 34394353
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
8. WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.
Wei YB; Liang DM; Zhang ML; Li YJ; Sun HF; Wang Q; Liang Y; Li YM; Wang RR; Yang ZL; Wang P; Xie SY
Front Oncol; 2022; 12():1032850. PubMed ID: 36387210
[TBL] [Abstract][Full Text] [Related]
9. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
10. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.
Yuan Y; Du Y; Wang L; Liu X
J Cancer; 2020; 11(12):3588-3595. PubMed ID: 32284755
[TBL] [Abstract][Full Text] [Related]
11. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.
Mu X; Zhao Q; Chen W; Zhao Y; Yan Q; Peng R; Zhu J; Yang C; Lan K; Gu X; Wang Y
Front Oncol; 2020; 10():526866. PubMed ID: 33489865
[TBL] [Abstract][Full Text] [Related]
12. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.
Cheng Y; Fu Y; Wang Y; Wang J
Front Genet; 2020; 11():955. PubMed ID: 33061938
[TBL] [Abstract][Full Text] [Related]
13. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
[TBL] [Abstract][Full Text] [Related]
14. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers.
Tao Z; Zhao Y; Chen X
PeerJ; 2020; 8():e9589. PubMed ID: 32765970
[TBL] [Abstract][Full Text] [Related]
15. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.
Xia T; Wu X; Cao M; Zhang P; Shi G; Zhang J; Lu Z; Wu P; Cai B; Miao Y; Jiang K
Pathol Res Pract; 2019 Nov; 215(11):152666. PubMed ID: 31606241
[TBL] [Abstract][Full Text] [Related]
16. Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer.
Gong PJ; Shao YC; Yang Y; Song WJ; He X; Zeng YF; Huang SR; Wei L; Zhang JW
Front Oncol; 2020; 10():578963. PubMed ID: 33363011
[TBL] [Abstract][Full Text] [Related]
17. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
[TBL] [Abstract][Full Text] [Related]
18. N
Fry NJ; Law BA; Ilkayeva OR; Carraway KR; Holley CL; Mansfield KD
Oncotarget; 2018 Jul; 9(58):31231-31243. PubMed ID: 30131850
[TBL] [Abstract][Full Text] [Related]
19. Function of N6-Methyladenosine Modification in Tumors.
Zhang N; Zuo Y; Peng Y; Zuo L
J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Inhibit Triple-Negative Breast Cancer Cell Stemness and Metastasis via an ALKBH5-Dependent Mechanism.
Hu Y; Liu H; Xiao X; Yu Q; Deng R; Hua L; Wang J; Wang X
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
